Regulators in Europe have given the green light to Eli Lilly's erectile dysfunction drug Cialis as a treatment for enlarged prostate. Regulators in Europe have given the green light to Eli Lilly’s ...

Milestone reflects Eli Lilly and Company's commitment to bring new treatment options to millions of men who experience urological conditions INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Eli Lilly and ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

(Reuters) - U.S. drug regulators approved Eli Lilly's Cialis drug to treat enlargement of the prostate on Thursday, expanding use of the blockbuster impotence medicine. The Food and Drug ...

announced today that the European Commission has approved Cialis 5 mg for once daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cialis was approved for ...

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men ...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Tadalafil Mylan (Generics UK Ltd) for the treatment of men with ...

MIAMI, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the clinical trial of the Company’s proprietary Tadalafil and ...

Cialis is used to treat erectile dysfunction impotence and symptoms of benign prostatic hypertrophy enlarged prostate. Another brand of tadalafil is Adcirca, which is used to treat pulmonary arterial ...

Cialis becomes only medication approved in the EU for both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company ...